A Bioprocess Design for Microbial Production of Taxol

Project Summary

Paclitaxel (Taxol) is a small molecule drug belonging to the taxane family. It is one of the most commonly used chemotherapeutics, used for treatment of many cancers, as a monotherapy or in combination with other drugs to treat breast, lung and ovarian cancer as well as Kaposi’s sarcoma. Taxol is on the World Health Organization’s (WHO) List of Essential Medicines, a list that includes most the important medications for basic health. The worldwide demand for paclitaxel is exceeding the current supply. 

Themes and Categories
Health
Health Systems Operations
Year
2015

In addition the current cost of paclitaxel limits use in many parts of the developing world. Lower cost sources of paclitaxel can have an immediate impact to human health worldwide. Currently taxol is approved in the U.S. as first line of treatment for breast, ovarian and non-small cell lung cancer. The annual new cases of these cancers are ~ 540,000 in the United States.

Project Team

  • Banskota, S.
  • Ciesla T.J.
  • Moreb, E.

BME 590-02 Fall 2015 

Project Details

Market size: U.S. market : 1,100 kg per year

Process design included:

  • Genetically engineered E. coli Strain
  • Heterologous Taxol production pathway
  • Engineered host strain
  • GMP fermentation process
  • 5 step downstream recovery process 

Results

Our conceptual design results in cost competitive production 

  • $0.43/mg - including a 25% return
  • ~$ 5M in capital investment
  • Current pricing is ~ $0.50/mg 

Download the project poster for more details (PDF).

Related People

Related Projects

Understanding the Course of Disease via Registration on Electronic Health Records Data

A team of students led by Professor Anru Zhang (Duke Biostatistics & Bioinformatics, Computer Science, Mathematics, and Statistical Science) will develop methods to investigate the courses of complex diseases through electronic health records. The team will apply tensor methods to identify key features to register the patient's timeline. This work will provide a basis for researchers at Duke and elsewhere to sufficiently utilize the high-dimensional and longitudinal information in the electronic health record data. If time permitted, the related methods and theory will also be studied.

 

Project Lead: Anru Zhang

Project Manager: Rungang Han

Improving infection detection efficiency with wearables

A team of students led by researchers in the BIG IDEAs Lab will work to create a cloud-based infection detection platform that populates and translates wearable data from a variety of sources. The project will involve working with existing wearable data pipelines (e.g., APIs) to collect, process, and visualize wearable device data in real-time as well as implement machine learning techniques to produce insights of user health. The project will also involve app development and UI/UX considerations so that the platform is easily accessible and user friendly. The ultimate goal of this work is to inform wearable device users of changes in their health condition before more serious symptoms occur. 

 

Project Lead: Ali Roghanizad

Policy surveillance of UHC financing in Developing Countries

A team of students led by researchers at the Duke Center for Policy Impact in Global Health (CPIGH) will create a user-friendly interactive visualization tool to track the evolution of Universal Health Coverage (UHC) financing policies in the low- and middle-income countries. The students will use the UHC policy surveillance data collected by the CPIGH Bass Connections team in the Fall 2021 and Spring 2022 semesters. This publicly available data visualization will provide an opportunity for policymakers and researchers to conduct a quick comparative cross-country analysis and longitudinal analysis to understand the impact of different policy experiments on UHC progress in different jurisdictions.

Project Lead: Osondu Ogbuoji

Project Manager: Luke Fesko

See all Research